Big Alliances a Prerequisite for Big Market Caps in Diagnostics
Executive Summary
Since 1990, only four diagnostic companies have breached the $100 million company valuation mark with their initial public offerings. Two factors which seem to be the common thread: Innovative technology and major alliances with larger, well-established companies.